I loathe to agree with Lape, but trials are expensive...
They'll need to be funded somehow, hopefully they're run in collaboration with a pharma and they're covering expenses. But that's probably wishful thinking at this stage.
Also, hopefully the trial results are transferable to Australia to affect licences and permissions. I'm not sure how overseas trials are treated here.
Anyone know more?
Cheers
Ann: Trading Halt, page-21
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.020(8.70%) |
Mkt cap ! $12.10M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 26.0¢ | 19.0¢ | $16.75K | 67.95K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2200 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.0¢ | 580 | 1 |
View Market Depth
| Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
| RGT (ASX) Chart |